Search / 13 results found

from
to
  • Updated

THURSDAY, Jan. 13, 2022 (HealthDay News) -- While COVID-19 has taken the lives of many children and caused serious illness for many more, it is generally agreed that the virus is much less likely to inflict severe damage in the young.

  • Updated

THURSDAY, Jan. 6, 2022 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention on Wednesday endorsed the emergency use of the Pfizer booster shots for children ages 12 to 17 years, expanding protection to adolescents and teens as students return to classes and the highly contagious omicron variant surges across the country.

  • Updated

TUESDAY, Jan. 4, 2022 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention on Tuesday backed the emergency use approval of the Pfizer COVID-19 booster shot for high-risk children between the ages of 5 and 11 years, along with shortening the time period between a second dose and a booster shot from six months to five months.

TUESDAY, Jan. 4, 2022 (HealthDay News) -- The U.S. Centers for Disease Control and Prevention on Tuesday backed the emergency use approval of Pfizer's booster shot for high-risk kids between the ages of 5 and 11, along with shortening the time period between a second dose and a booster shot from six months to five months.

  • Updated

TUESDAY, Dec. 21, 2021 (HealthDay News) -- In record time, the Omicron variant has become the dominant variant in the United States, accounting for 73% of new infections last week, the U.S. Centers for Disease Control and Prevention said Monday.

  • Updated

FRIDAY, Dec. 17, 2021 (HealthDay News) -- Unvaccinated students exposed to COVID-19 can remain in the classroom as long as they're regularly tested for the virus at school, the U.S. Centers for Disease Control and Prevention said Friday.